$AXSM News

HC Wainwright & Co. Reiterates Buy on Axsome Therapeutics, Maintains $290 Price Target

RBC Capital Maintains Outperform on Axsome Therapeutics, Raises Price Target to $304

Axsome Therapeutics Doses First Patient In FOCUS-2 Phase 3 Trial Of Solriamfetol For Children With Attention Deficit Hyperactivity Disorder

Axsome Therapeutics Announces First Patient Dosed In FOCUS-3 Phase 3 Trial Evaluating Solriamfetol As Treatment For Adolescents With Attention Deficit Hyperactivity Disorder

TD Cowen Maintains Buy on Axsome Therapeutics, Raises Price Target to $300

Axsome to Present New Sleep Disorder Data at SLEEP 2026, To Highlight AXS-12 and Solriamfetol Data for Narcolepsy and OSA

Rapport ‘fully prepared’ to launch seizure drug solo, CEO says

Axsome Therapeutics, Inc. (AXSM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Axsome Therapeutics Readies Auvelity Alzheimer’s Agitation Launch, Expands CNS Pipeline

Does SUNOSI Patent Peace And New Migraine Data Change The Bull Case For Axsome Therapeutics (AXSM)?

Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting

Why Is Axsome (AXSM) Down 0.4% Since Last Earnings Report?

Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigation

Axsome Therapeutics Resolves All Patent Litigation Related To Axsome's Product SUNOSI

Axsome Therapeutics Partners with the Headache Alliance to Highlight the Impact of Migraine During Migraine and Headache Awareness Month

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Axsome Therapeutics Presents New AUVELITY® Data in Major Depressive Disorder at the American Society of Clinical Psychopharmacology (ASCP) 2026 Annual Meeting

Axsome's Auvelity: A New Treatment For Agitation In Alzheimer's Disease

Axsome Therapeutics Bets on AUVELITY Expansion With June Alzheimer’s Agitation Launch

Axsome Therapeutics, Inc. (AXSM) Presents at Bank of America Global Healthcare Conference 2026 Transcript